Clifford Swan Investment Counsel’s GE HealthCare GEHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-2,989
Closed -$213K 346
2026
Q1
$213K Sell
2,989
-568
-16% -$44.8K 0.01% 321
2025
Q4
$292K Sell
3,557
-395
-10% -$30.8K 0.01% 265
2025
Q3
$297K Sell
3,952
-202
-5% -$15.1K 0.01% 273
2025
Q2
$308K Sell
4,154
-954
-19% -$66.4K 0.01% 260
2025
Q1
$412K Sell
5,108
-82
-2% -$7.05K 0.02% 230
2024
Q4
$406K Sell
5,190
-6,415
-55% -$545K 0.01% 234
2024
Q3
$1.09M Sell
11,605
-162
-1% -$13.6K 0.04% 174
2024
Q2
$917K Sell
11,767
-242
-2% -$19.7K 0.03% 178
2024
Q1
$1.09M Sell
12,009
-626
-5% -$52.1K 0.04% 169
2023
Q4
$977K Sell
12,635
-2,326
-16% -$163K 0.04% 176
2023
Q3
$1.02M Sell
14,961
-1,154
-7% -$84K 0.04% 169
2023
Q2
$1.31M Sell
16,115
-1,119
-6% -$89.3K 0.05% 159
2023
Q1
$1.41M Buy
+17,234
New +$1.23M 0.06% 153

Other funds holding GEHC

Clifford Swan Investment Counsel's GEHC Position: Q2 2026 in Review

Clifford Swan Investment Counsel sold out of GE HealthCare (GEHC) in Q2 2026, closing a stake of 2,989 shares — an estimated $213K sold.

Clifford Swan Investment Counsel first reported a position in GEHC in Q1 2023 and held it in 13 quarters. The position peaked at $1.41M in Q1 2023. 1,223 funds tracked by Wall St. Rank hold GEHC as of Q2 2026.

  • Clifford Swan Investment Counsel reported no remaining GE HealthCare position as of Q2 2026 after selling out during the quarter.
  • Clifford Swan Investment Counsel sold 2,989 GE HealthCare shares in Q2 2026, an estimated $213K.
  • Clifford Swan Investment Counsel first reported a position in GE HealthCare in Q1 2023 and held it in 13 quarters.
  • Clifford Swan Investment Counsel's GE HealthCare position peaked at $1.41M in Q1 2023.
  • 1,223 funds tracked by Wall St. Rank held GE HealthCare as of Q2 2026.

Based on Clifford Swan Investment Counsel's 13F filing for Q2 2026, filed 20 Aug 2026.